OncoC4

Rockville, United States

OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.

$50.0M raised

Oct 2025

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has OncoC4 raised?

OncoC4 has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in October 2025.

Who are OncoC4's investors?

OncoC4's investors include 3E Bioventures, Kaitai Capital, HM Capital, GBA Fund.

Where is OncoC4 headquartered?

OncoC4 is headquartered in Rockville, United States.

What does OncoC4 do?

OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.

What stage is OncoC4 at?

OncoC4 is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 2, 2025.

MLA

"OncoC4 — Funding & Investors." VCBacked, October 2, 2025, https://www.vcbacked.co/company/oncoc4. Accessed July 2, 2026.

APA

VCBacked. (2025). OncoC4 — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/oncoc4

Wikipedia (cite web)

{{cite web |title=OncoC4 — Funding & Investors |url=https://www.vcbacked.co/company/oncoc4 |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 2, 2025.